Pure Global AI
PMDA Document

PMDA MD/IVD fee table — revision 20 May 2022

Medical-device and IVD review fees — complete PMDA table revised 20 May 2022
JapanPharmaceuticals and Medical Devices AgencyRegistrationCurrentness under review
Document status

Currentness under review. Whether this instrument remains applicable is under review. Consult the later instruments and source context below before relying on it.

Document identity

Medical-device and IVD review fees — complete PMDA table revised 20 May 2022 is published by Pharmaceuticals and Medical Devices Agency. This document is identified by its title; no separate official document code is recorded.

Instrument
Document
Full name
PMDA MD/IVD fee table — revision 20 May 2022
Category
Registration
Source links
Source publication
Japanese
Linked source text; confirm the publisher, publication details and any later amendment or consolidated version.
Readable HTML
1 language version
Direct citations can link to a specific article or section by appending its fragment identifier.
Dates
Published
—
Effective
—
Readable full text

Open a language version

Each version has stable passage anchors for direct citations and highlighting. The readable text is generated from an authority source and does not replace the legally controlling publication.

About this regulation

Medical-device and IVD review fees — complete PMDA table revised 20 May 2022

Complete eight-page Japanese PMDA fee-table expression with its printed revision of 20 May 2022, review/conformity columns, article references and footnotes. This is a historical table expression; it does not establish current fees or a universal fee for every corporate, product-name or model change. The unchanged native extraction preserves a qualified search layer, while full original page images preserve the table layout. No fee data, currentness assertion or completed-question determination is added.

This document is identified by its title; no separate official document code is recorded. Always confirm the current consolidated text and transition provisions with the official source before filing.